EP3986561
PYRIDO[2,3-D]PYRIMIDINE DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
17.6.2020EP published:
14.2.2024EP application number:
20743783.1
EP translation filed:
27.3.2024Grant published:
15.5.2024EPO information:
European Patent Register
Max expiry date:
16.6.2040Expiry date:
16.6.2026Next due date:
30.6.2026
Title in English:
PYRIDO[2,3-D]PYRIMIDINE DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATIONLanguage of the patent:
English
Timeline
Today
17.6.2020EP application
14.2.2024EP Publication
27.3.2024Translation submitted
15.5.2024Registration published
16.6.2026Expires
Owner
Name:
VIIV Healthcare UK (No.5) LimitedAddress:
GSK Medicines Research Centre Gunnels Wood Road, Stevenage SG1 2NY, GB
Inventor
Name:
GILLIS, Eric PAddress:
Branford, Connecticut 06405, US
Name:
IWUAGWU, ChristianaAddress:
Wallingford, Connecticut 06492, US
Priority
Number:
201962863406 PDate:
19.6.2019Country:
US
Classification
Categories:
A61P 31/18, C07D 471/04, A61K 31/519
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 23.5.2024
Expires: 16.6.2025
Payer: Árnason Faktor ehf.
Number: 6
Paid: 12.6.2025
Expires: 16.6.2026
Payer: Árnason Faktor ehf.